Agonist Therapy | List of Frontiers open access articles

Original Research

Published on 17 Jan 2022

Intranasal Oxytocin for Stimulant Use Disorder Among Male Veterans Enrolled in an Opioid Treatment Program: A Randomized Controlled Trial

in Addictive Disorders

Christopher S. Stauffer
Salem Samson
Alex Hickok
William F. Hoffman
Steven L. Batki

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.804997

6,338 views
7 citations

Opinion

Published on 20 Jan 2025

Biological mechanisms of dopamine D2-like receptor agonist therapy in diabetes

in Translational and Clinical Endocrinology

Zachary Freyberg
Ronald A. Codario

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1532414

2,137 views
2 citations

Original Research

Published on 02 Feb 2018

Liver X Receptor Agonist Therapy Prevents Diffuse Alveolar Hemorrhage in Murine Lupus by Repolarizing Macrophages

in Inflammation

Shuhong Han
Haoyang Zhuang
Stepan Shumyak
Jingfan Wu
Chao Xie
Hui Li
Li-Jun Yang
Westley H. Reeves

Frontiers in Immunology

doi 10.3389/fimmu.2018.00135

7,363 views
46 citations

Original Research

Published on 29 Nov 2023

Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy

in Pituitary Endocrinology

Linjie Wang
Xiaojing Wang
Fengying Gong
Hui Pan
Huijuan Zhu

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1285477

2,568 views
7 citations

Original Research

Published on 09 Jun 2023

The four-factor personality model and its qualitative correlates among opioid agonist therapy clients

in Addictive Disorders

Ioan T. Mahu
Patricia J. Conrod
Sean P. Barrett
Aïssata Sako
Jennifer Swansburg
Sherry H. Stewart

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1129274

4,552 views
3 citations

Original Research

Published on 10 Aug 2023

A qualitative study on people with opioid use disorders’ perspectives on smoking and smoking cessation interventions

in Addictive Disorders

Karl Trygve Druckrey-Fiskaaen
Einar Furulund
Tesfaye Madebo
Siv-Elin Leirvåg Carlsen
Lars T. Fadnes
Torgeir Gilje Lid
for ATLAS4LAR Study Group
Vibeke Bråthen Buljovcic
Jan Tore Daltveit
Karl Trygve Druckrey-Fiskaaen

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1185338

4,858 views
5 citations

Mini Review

Published on 12 Mar 2021

Impulse Control Disorders in Parkinson’s Disease: From Bench to Bedside

in Neurodegeneration

Andrea Augustine
Catharine A. Winstanley
Vaishnav Krishnan

Frontiers in Neuroscience

doi 10.3389/fnins.2021.654238

9,943 views
24 citations

Original Research

Accepted on 11 Feb 2026

Factors influencing family physicians' willingness to prescribe opioid agonist therapy using virtual modalities: a qualitative analysis

in Family Medicine and Primary Care

Sarah Munoz-Violant
Sarah Spencer
Ellie Gooderham
Shawna Narayan
Bohdan Nosyk
Rita Katherine McCracken
Lindsay Hedden

Frontiers in Medicine

224 views

General Commentary

Published on 06 Mar 2024

Commentary: Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy

in Pituitary Endocrinology

Lukas Andereggen
Emanuel Christ

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1371468

1,652 views
1 citation

Original Research

Published on 11 Feb 2019

Pelvic Ultrasound in Diagnosing and Evaluating the Efficacy of Gonadotropin-Releasing Hormone Agonist Therapy in Girls With Idiopathic Central Precocious Puberty

in Translational Pharmacology

Hong-kui Yu
Xiao Liu
Jia-kun Chen
Shan Wang
Xian-yue Quan

Frontiers in Pharmacology

doi 10.3389/fphar.2019.00104

15,059 views
25 citations

Review

Published on 09 Dec 2024

Effects of pretreatment strategies on fertility outcomes in patients with adenomyosis

in Assisted Reproduction

Gaby Moawad
Youssef Youssef
Arrigo Fruscalzo
Slim Khedhri
Hani Faysal
Paul Pirtea
Benedetta Guani
Alexandre Vallée
Jean Marc Ayoubi
Anis Feki

Frontiers in Reproductive Health

doi 10.3389/frph.2024.1484202

5,886 views
4 citations

Original Research

Published on 04 Jan 2024

Re-examining provider perceptions of best pre-war practices: what elements can help opiate agonist therapy programs in Ukraine successfully survive the crisis?

in Public Mental Health

P. Dellamura
A. Meteliuk
T. Fomenko
J. Rozanova

Frontiers in Public Health

doi 10.3389/fpubh.2023.1259488

3,220 views
1 citation

Original Research

Published on 31 Aug 2023

The experience of buprenorphine implant in patients with opioid use disorder: a series of narrative interviews

in Addictive Disorders

Pietro Scurti
Marco Nunzi
Claudio Leonardi
Claudio Pierlorenzi
Roberta Marenzi
Vincenzo Lamartora

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1205285

3,329 views
7 citations

Mini Review

Published on 23 Oct 2024

Achieving HIV epidemic control through accelerating efforts to expand access to pre-exposure prophylaxis for people who inject drugs

in HIV and STIs

Lirica Nishimoto
Adaobi Lisa Olisa
Philip Imohi
Judy Chang
Chris Obermeyer
Dama Kabwali
Christopher Akolo

Frontiers in Reproductive Health

doi 10.3389/frph.2024.1438005

3,335 views

Case Report

Published on 28 Feb 2022

Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case Report

in Clinical Diabetes

Angela Dardano
Michele Aragona
Giuseppe Daniele
Roberto Miccoli
Stefano Del Prato

Frontiers in Endocrinology

doi 10.3389/fendo.2022.847778

5,679 views
4 citations

Original Research

Published on 30 Nov 2023

Introducing methadone maintenance therapy into Ukrainian prisons: a qualitative study of criminal subculture, Russia’s full-scale invasion, and contested methadone objects

in Addictive Disorders

Matthew Ponticiello
Lyu Azbel
Mary M. Tate
Daniel J. Bromberg
Iryna Pykalo
Tetiana Kiriazova
Natalya Saichuk
Frederick L. Altice

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1227216

3,929 views
5 citations

Articles

Intranasal Oxytocin for Stimulant Use Disorder Among Male Veterans Enrolled in an Opioid Treatment Program: A Randomized Controlled Trial

Biological mechanisms of dopamine D2-like receptor agonist therapy in diabetes

Liver X Receptor Agonist Therapy Prevents Diffuse Alveolar Hemorrhage in Murine Lupus by Repolarizing Macrophages

Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy

The four-factor personality model and its qualitative correlates among opioid agonist therapy clients

A qualitative study on people with opioid use disorders’ perspectives on smoking and smoking cessation interventions

Impulse Control Disorders in Parkinson’s Disease: From Bench to Bedside

Factors influencing family physicians' willingness to prescribe opioid agonist therapy using virtual modalities: a qualitative analysis

Commentary: Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy

Pelvic Ultrasound in Diagnosing and Evaluating the Efficacy of Gonadotropin-Releasing Hormone Agonist Therapy in Girls With Idiopathic Central Precocious Puberty

Effects of pretreatment strategies on fertility outcomes in patients with adenomyosis

Re-examining provider perceptions of best pre-war practices: what elements can help opiate agonist therapy programs in Ukraine successfully survive the crisis?

The experience of buprenorphine implant in patients with opioid use disorder: a series of narrative interviews

Achieving HIV epidemic control through accelerating efforts to expand access to pre-exposure prophylaxis for people who inject drugs

Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case Report

Introducing methadone maintenance therapy into Ukrainian prisons: a qualitative study of criminal subculture, Russia’s full-scale invasion, and contested methadone objects